Jump to content
RemedySpot.com

Barbs in Lyon, FR

Rate this topic


Guest guest

Recommended Posts

Dear Barb,

I'm so sorry that it took the bad news about your friend to hear from you again.

I know how involved you are with CML in France and like you, I never thought I

would ever

utter the words, I am glad I have CML. At least we have some treatments that

are

working for the majority, some moreso than others. It is always a source of

great joy when someone proclaims their latest triumph of PCRU.

This is a position not easily taken, but in lieu of the number of drugs

available to CML patients, we are lucky, indeed. It certainly is appropriate to

discuss other types of cancer, especially since several of our members have

secondary cancers. We cannot ignore the fact that it is occurring more often

than we think. Our group is a small population compared to world wide stats and

it is happening everywhere in our CML community.

Sometimes I think the information is deliberitely withheld from us, but we need

to be aware of it. Last week I posted some information on data that was

collected in Switzerland and there is recorded data that after being on Gleevec

for 2 years, that is a crucial time. I know you are doing quite well with

Gleevec and cooperated in the Spirit trial for a while. I hope Dr. Nicolini is

still doing CML research and keeping you informed. Your vacation cards and

pictures are always appreciated.

xoxox to you and yours,

Lottie

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...